Luk H. Vandenberghe, PhD, Harvard Medical School Associate Professor of Ophthalmology and Director of the Grousbeck Gene Therapy Center at Mass. Eye and Ear, has been named the first incumbent of the Grousbeck Family Chair in Gene Therapy at Mass. Eye and Ear.
Dr. Vandenberghe is one of the world’s foremost experts in therapeutic gene transfer. He and the scientists at the Grousbeck Center are working to develop safe and effective gene delivery technologies and genetic therapies. His laboratory interests are focused on the treatment of blinding disorders, synthetic biology and engineering approaches, and the biology and mechanisms of somatic gene transfer. Dr. Vandenberghe is an author on over 70 publications and an inventor on more than a dozen technologies, several of which are licensed and in clinical studies. He co-founded two gene therapy biotech companies and the non-profit Odylia Therapeutics focused on the development of gene therapies for ultra-rare blinding disorders.